Navigation Links
Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K
Date:3/31/2009

vements discussed in or implied by the forward-looking statements contained herein. Alseres is providing the information in this press release as of this date and assumes no obligations to update the information in this press release.

Alseres, Cethrin and Altropane are registered trademarks of Alseres Pharmaceuticals, Inc.

http://www.alseres.com/

    Contact:
    Kenneth L. Rice 508-497-2360 x226
    Alseres Pharmaceuticals, Inc.
    krice@alseres.com


'/>"/>
SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
2. Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
3. Alseres Pharmaceuticals, Inc. Raises $5 Million
4. Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
5. Alseres Pharmaceuticals to Host 2007 Financial Results Conference Call
6. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
7. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
8. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
9. Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc.
10. Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE)
11. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., MISSISSAUGA,ON,Nov.23/PRNewswire-FirstCall/-YMB...sproductdevelopmentcompanythatidentifiesandadvance...satvariousstagesofdevelopment,todayreportedthatCyt...alevaluatingCYT387,apotent,orally-administeredJAK1...cinRochester,Minnesota.AproposaltomergeCytopiainto...
(Date:11/23/2009)... Contec’s Sporicidin dis...ctive hospital-grade disinfectants against H1N1 an...burg, SC (PRWEB) November 24, 2009 -- Contec Inc, ... has announced that their Sporicidin disinfectant...t all Influenza A viruses, including Pandemic 2009...
(Date:11/23/2009)..., BURNABY,BC,Nov.23/PRNewswire/-InimexPharmaceuti...Abrams,Ph.DasitsPresidentandCEO. ,, Abramsbring...iencetoInimex.Heisaco-inventorofthenuclearmedicine...ohnsonMatthey,plcwherehewasManager,BiomedicalResea...rMEDinLangley,BCandwasPresidentandCEOfrom1996to200...
(Date:11/23/2009)..., REDWOODCITY,Calif.,Nov.23/PRNewswire/--PearlThe...herapeuticproductsforthetreatmentofchronicrespirat...entothecompany,sBoardofDirectors.Mr.Rosenhas25year...dustries,includingkeyrolesatGileadSciencesandALZAC...torsonPearl,sBoardtosix. ,, "Howiebringsawealth...
Breaking Biology Technology:YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Inimex Announces Appointment of New CEO 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2
...olczynski is the technology consultant to the vice...But on evenings and weekends, he,s an entrepreneur...ish Flutes, is not a huge money maker. "My take o... has spent developing and running a global e-comme...eal about the importance of keeping one,s customer...
..., we looked at venture capital funding in the U.S....bout $5 billion in investments in small companies.... $5.4 billion invested during the fourth quarter o...yTree analysis. , ,The results for the second qua...enture capital investments achieved a two-year hig...
... the United States was hit with the largest blacko...ion failures exposed holes in the grid that were p...nsin power companies, now that preparing for a sim...,The blackouts effects were unprecedented, shuttin...tates and Canada21 in the first three minutes alon...
Other Biology Technology:Irish flute passion drives e-commerce spirit for Eaton techie 2Irish flute passion drives e-commerce spirit for Eaton techie 3Midwest life science companies capture 3% of VC investments in Q.2 2One year after the 2003 blackout: Is Wisconsin prepared? 2One year after the 2003 blackout: Is Wisconsin prepared? 3
(Date:11/24/2009)... Stents that keep weakened and flabby arteries fr...r six months, those stents are no longer needed --...nnecessary. Previously, doctors had no choice but ... of Tel Aviv University,s Department of Biomedical...ber platform that carries drugs where they,re need...
(Date:11/24/2009)... What constitutes fish food is a matter of debat...that fish get almost 50 percent of their carbon fr...k between the terrestrial and aquatic ecosystems. ...gton shows this is not likely to be true. Algae pr...c life, according to research published this week ...
(Date:11/23/2009)... , Cambridge, Mass. November 23, 2009 Applied...antain lily ( Hosta lancifolia ), a characteristic...losely packed ripples along the edges. The simple ...on resulting from bending during differential grow...e, stretching foam ribbons. , Haiyi Liang, a pos...
Breaking Biology News(10 mins):A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2Coapt Systems Inc Launches Hydrelle 28TM 29 a New FDA Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient 50731 1Coapt Systems Inc Launches Hydrelle 28TM 29 a New FDA Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient 50731 2Coapt Systems Inc Launches Hydrelle 28TM 29 a New FDA Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient 50731 3Coapt Systems Inc Launches Hydrelle 28TM 29 a New FDA Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient 50731 4American Orthopaedic Society for Sports Medicine 28AOSSM 29 Presents Prestigious Research Awards at Annual Meeting 50726 1American Orthopaedic Society for Sports Medicine 28AOSSM 29 Presents Prestigious Research Awards at Annual Meeting 50726 2American Orthopaedic Society for Sports Medicine 28AOSSM 29 Presents Prestigious Research Awards at Annual Meeting 50726 3American Orthopaedic Society for Sports Medicine 28AOSSM 29 Presents Prestigious Research Awards at Annual Meeting 50726 4American Orthopaedic Society for Sports Medicine 28AOSSM 29 Presents Prestigious Research Awards at Annual Meeting 50726 5McCaughey Urges Use of First NYS Hospital Infection Report 4681 1
...ing stem cells found in testicles could be extract... team in the Netherlands has successfully harveste... them inside mouse testes. The hope is that the sa...omising route to help young cancer patients underg...rsity, Netherlands, told participants gathered at ...
...ective against not only multi drug-resistant forms...nd to treat the latent stage of infection as well....06 ASM Biodefense Research Meeting. , "The class ...erent mechanism of action from any other drug curr...ied no cross resistance with existing drugs. Ever...
...reased risk of the most common type of brain tumou...tween mobile phone use and risk of glioma. The res...four year study by the Universities of Leeds, Nott...Research, London found those who had regularly use...k of developing this type of tumour. , There was ...
Other Biology News:Testes to incubate stem cells 2Experimental TB drug effective against resistant and latent mycobacterium tuberculosis 2Mobile phone use not linked to increased risk of glioma brain tumours 2
Calcium Phosphate Transfection Kit from Invitrogen
Custom siRNA, HPLC purified, annealed from Ambion
Custom siRNA, HPLC purified from Ambion
Silencer In Vivo Ready siRNAs from Ambion
Biology Products: